Blinded Prediction of Protein-Ligand Binding Affinity Using Amber Thermodynamic Integration for the 2018 D3R Grand Challenge 4

24 June 2019, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

In the framework of the 2018 Drug Design Data Resource (D3R) grand challenge 4, blinded predictions on relative binding free energy were performed for a set of 39 ligands of the Cathepsin S. We leveraged the GPU-accelerated thermodynamic integration (GTI) of Amber 18 to advance our computational prediction. When our entry was compared to experimental results, good correlation was observed (Kendall’s τ: 0.62, Spearman’s ρ: 0.80 and Pearson’s R: 0.82), with the highest correlation to experiment among all submissions. We designing a parallelized transformation map that placed ligands into several groups based on common alchemical substructures; TI transformations were carried out for each ligand to the relevant substructure, and between substructures. Our calculations were all conducted using the linear potential scaling scheme in Amber TI because we believe the softcore potential/dual topology approach implemented in current Amber TI is highly fault-prone. The issue was illustrated by using two examples in which typical preparation for the dual topology approach of Amber TI fails. Overall, the high accuracy of our prediction is a result of recent advances in force fields (ff14SB and GAFF), as well as rapid calculation of ensemble averages enabled by the GPU implementation of Amber. The success in a blinded prediction strongly suggests that alchemical free energy calculation in Amber is a promising tool for future commercial drug design.

Keywords

Drug design
binding affinity
alchemical free energy calculations
thermodynamic integration
Amber
molecular dynamics
D3R

Supplementary materials

Title
Description
Actions
Title
Simmerling D3R 6-23-2019 SI
Description
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.